The core activity of iGreen Swiss S.A. is the development, production and distribution of medical cannabis and its derived products, in particular Tetrahydrocannabinol (THC) and Cannabidiol (CBD), for therapeutic purposes. The company is active in all phases of the value chain, from research and development to the manufacture and marketing of medical cannabis and its derived products.
AI-generated
Offering
Products & services
Industry:
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Medical cannabis flowers and oils produced in Switzerland, organic, free of pesticides or chemical products, for pharmacies, research and pharmaceutical use.
Medical cannabis
Therapeutic cannabis to relieve pain, nausea, anxiety, insomnia, spasms and other symptoms, with THC, CBD and other cannabinoids.
Pilot programs
Supply of certified raw materials for Swiss pilot projects approved by the OFSP, to support regulatory and distribution models for cannabis.
Tailored solutions for research and the pharmaceutical industry
Solutions tailored to the specific needs of research, studies and the pharmaceutical industry, in addition to standard products.
Information and support for healthcare professionals
Information on suitable varieties, routes of administration and current research, with support for doctors, pharmacists and other professionals.
Knowledge
No knowledge articles yet
Once iGreen Swiss SA has claimed this profile, we'll publish editorial articles and case studies here together.